Mauro F. Guillén is one of the most original thinkers at the Wharton School…

Austin Tang — Tue, 13 Oct 2020 17:36:04 +0000

http://goodnewsplanet.com/wp-content/uploads/2020/10/mauro_gillen_1.mp3
where he holds the Zandman Professorship in International Management and teaches in its flagship Advanced Management Program and many other courses for executives, MBAs, and undergraduates. An expert on global market trends, he is a sought-after speaker and consultant. He combines his training as a sociologist at Yale and as a business economist in his native Spain to methodically identify and quantify the most promising opportunities at the intersection of demographic, economic and technological developments. His online classes on Coursera and edXhave attracted over 100,000 participants from around the world. He has won multiple teaching awards at Wharton, where his presentation on global market trends has become a permanent feature of over fifty executive education programs annually.

His research, teaching, and speaking incorporates both numerical assessments of trends and illuminating examples from business, politics, and everyday life. He shows in accessible terms that one can accurately forecast trends by systematically following the babies and following the money into the future. His research has earned him many distinctions, including Fulgright, Rockefeller and Guggenheim fellowships, a membership in the Institute for Advanced Study in Princeton, and prizes from the Academy of Management, the American Sociological Association, the Social Science History Association, and the Gustavus Myers Center for the Study of Bigotry and Human Rights. He is an elected member of the Sociological Research Association and the MacroOrganizational Behavior Society.

The post Mauro F. Guillén is one of the most original thinkers at the Wharton School… appeared first on Good News!.

A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.

Austin Tang — Wed, 04 Mar 2020 18:55:41 +0000

http://goodnewsplanet.com/wp-content/uploads/2020/03/leukemia_1.mp3
There are a variety of reasons why treatments fail, and patients need to work with their healthcare team to explore their options if treatment failure occurs.
Herewith tips for patients, are Dr. Michael Mauro, (More-oh) and Karen, who is living with chronic myeloid leukemia, or CML.
BIO:DR. MICHAEL MAURO:
• Michael Mauro, MD, Professor of Medicine, Member and Attending Physician and Leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
o Dr. Mauro’s clinical expertise is in treating patients with chronic myeloid leukemia (CML), as well as other myeloproliferative disorders, including myelofibrosis, polycythemia and thrombocytosis. In practice, he offers in-depth explanation regarding diagnoses and therapy options, and is a proponent of active partnerships with his patients to personalize decision-making and monitoring. He is a board-certified hematologist and leader of the Myeloproliferative Neoplasms Program within the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSKCC). Before joining Memorial Sloan Kettering, Dr. Mauro was on the faculty of Oregon Health and Sciences University for 13 years. There, he directed the CML clinical trial program. He completed both residency and fellowship training at New York-Presbyterian Hospital / Weill Cornell Medical College in New York City.
o Location: Practices in both Manhattan (NYC) and Montvale, NJ campuses of MSKCC
o Specialty/Areas of Focus: Chronic Myeloid Leukemia; Myelofibrosis; Polycythemia; Thrombocytosis, Other Myeloproliferative Disorders
o Education: MD, Dartmouth Medical School
o Board Certifications: Hematology
BIO:KAREN L.
o Bio: Karen is a teacher, former runner turned yogi, wife and mother of two from Eden Prairie, Minnesota.
o Journey with CML:
§ When she began losing excessive weight and noticed a weakness in her legs during runs, she initially attributed these symptoms to turning 40 years old. Eventually she decided to visit her doctor, but her doctor was not concerned and told her to come back in a few months if she was still experiencing the same symptoms.
§ A few months later, Karen returned to her doctor for an ultrasound, which revealed her spleen was enlarged. Following a blood test, a nurse called Karen and told her it was suspected she had blood cancer and urged Karen to come straight to the hospital. The nurse expressed concerns about her potentially being at risk for a stroke. After further testing, it was confirmed that Karen had chronic myeloid leukemia (CML). Karen spent several days in the hospital to help regulate the CML. After she was released from the hospital, Karen started taking a daily medication to help control the CML. Eventually Karen was able to return to teaching and her usual activities.
§ Following her initial diagnosis, Karen developed a genetic mutation that caused her treatment for CML to stop working. Since there were no available treatment options effective against the mutation, Karen enrolled in a clinical trial and responded well to the treatment she was given.
§ Today,Karen remains on the medication she took in the clinical trial and is stillteaching.
#leukemia #diagnosis #treatment #plan #patients #need #michael #mauro #cml #chronic #myeloid #karen #medicine #physician #myeloproliferative #neoplasms #program #memorial #sloan #kettering #cancer #center #new #york #ny #teacher #yoga #education

The post A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next. appeared first on Good News!.

mauro Archives - Good News!

Mauro F. Guillén is one of the most original thinkers at the Wharton School…

A leukemia diagnosis is devastating – and when the first steps in a treatment plan fail, patients can wonder what happens next.